Blood Serum Amyloid A as Potential Predictor of Response to First-Line Pembrolizumab in Patients with Advanced Non-Small-Cell Lung Cancer

被引：0

作者：

Di Noia, V. ^{[1
]}

Carbone, C. ^{[2
]}

Vita, E. ^{[1
]}

Ferrara, M. ^{[1
]}

D'Argento, E. ^{[2
]}

Lucchetti, D. ^{[3
]}

Damiano, P. ^{[1
]}

Virtuoso, A. ^{[1
]}

Ribelli, M. ^{[1
]}

Cannella, A. ^{[1
]}

Battaglia, A. ^{[4
]}

Fattorossi, A. ^{[4
]}

Sgambato, A. ^{[3
]}

Tortora, G. ^{[1
]}

Bria, E. ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Inst Med Interna, Rome, Italy

[2] Fdn Policlin Univ A Gemelli Irccs, Comprens Canc Ctr, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Ist Patol Gen, Rome, Italy

[4] Fdn Policlin Univ A Gemelli Irccs, Dept Woman & Child Hlth, Rome, Italy

来源：

关键词：

NSCLC; Pembrolizumab; predictive factor;

D O I：

10.1016/j.jtho.2019.08.784

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.01-69

引用

页码：S386 / S387

页数：2